Editorial: Guidelines for choosing drugs in chronic heart failure ||FREE PAPER||

Abstract

Reza TabrizchiDivision of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St John’s, NL, CanadaIn a recent article, Komajda and colleagues (2005) presented data gathered from the Medical Management of Chronic Heart Failure in Europe and its Related Costs (MAHLER) survey in support of the view that adherence to guidelines in treating patients with chronic heart failure is a strong predictor of fewer cardiovascular hospitalizations in clinical practice.